Why have I not lost any weight on Mounjaro?

Weight loss on Mounjaro is rarely linear — short plateaus and slow weeks are well-documented in clinical trial data, including the SURMOUNT-1 programme.
The 2.5mg and 5mg starter doses are primarily about helping your body adjust; meaningful weight change is more closely linked to maintenance doses reached through titration.
Factors including sleep quality, stress hormones, fluid retention and medication interactions can all mask fat loss on the scales even when body composition is changing.
If you have been on a stable maintenance dose for more than six weeks without any change, that is worth raising with your prescriber, not waiting out indefinitely.

If your weight hasn't shifted on Mounjaro, you are not alone — and there are usually clear, identifiable reasons. Weight loss on tirzepatide does not follow a straight line for everyone, and some people see little change in the early weeks or after a dose increase, even when they are doing everything right. These are prescription-only medicines: a clinical assessment with a registered prescriber is the right place to work through what's happening in your specific case. This page explains the most common reasons progress stalls, and what the evidence says about timelines.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What's actually behind the stall, and what to do about it

Is Mounjaro even at a dose where weight loss is expected yet?

This is the first question worth sitting with honestly. The treatment schedule for tirzepatide starts at 2.5mg, and that dose has one job: settling your system before the therapeutic work begins. Clinical trial results (including data from the SURMOUNT-1 study, published in the New England Journal of Medicine) showed the largest and most consistent weight reductions at 10mg and 15mg. People on lower doses during titration often see modest or negligible scale changes, and that can feel alarming when you expected results from week one.

Titration typically moves in four-week steps, guided by the prescriber reviewing your response and tolerance. If you are three or four weeks into your first pen and the number has not moved, it may simply be that you have not yet reached the dose where tirzepatide does its substantive work. That is not failure. It is the schedule. Our guide on how Mounjaro works covers the titration pathway in more detail if you want the fuller picture.

The flip side: if you have been at a stable maintenance dose for six weeks or more and nothing has shifted, that is a different conversation, and if you haven't lost any weight on Mounjaro at that stage, it is one worth having with a prescriber rather than letting run on.

Could something else be working against the medicine?

Several factors can blunt or completely obscure weight loss even when tirzepatide is doing exactly what it should. The scales measure total body mass, not fat specifically, so fluid retention (which can spike with stress, poor sleep, high salt intake, or hormonal changes) can cancel out a week's worth of fat loss on paper. Some people also notice a brief weight plateau after a dose increase, which is the body recalibrating rather than the medicine failing.

Eating habits matter too. Tirzepatide reduces appetite and slows gastric emptying, but it does not create a deficit on its own if calorie intake has not fallen meaningfully. A common pattern in practice: appetite suppression kicks in, people feel full quickly, but the foods they do eat are calorie-dense enough that overall intake stays roughly the same. Alcohol is worth checking here, it carries significant calories that often go untracked.

Sleep and cortisol have a more direct effect than most people expect. Consistently poor sleep raises cortisol, which promotes fat storage and can drive hunger in ways that override reduced appetite. None of this is about willpower; it is biology. Our weight-loss overview touches on the lifestyle factors that work alongside treatment.

Finally, certain medications (including some antidepressants, antipsychotics and corticosteroids) can promote weight gain independently, and understanding why you haven't lost weight on Mounjaro sometimes comes down to identifying exactly these kinds of offsetting factors with your prescriber. If you are on other medicines, your prescriber should have this in view.

What does 'not losing weight' actually look like week to week?

There is an important difference between a week with no movement and a genuine plateau. The reasons weight doesn't move in a single week are often mundane: sodium, hydration, the timing of your weigh-in, whether you weighed in after a heavy meal or after a long day. A single static week is not a signal that treatment is failing.

A genuine plateau on Mounjaro is usually defined as four to six consecutive weeks at the same dose with no downward trend at all, when measured consistently at the same time of day. That is the point at which a prescriber would look at whether a dose increase is appropriate, whether there are offsetting factors to address, or whether the treatment is the right fit. The NHS tirzepatide information page is a solid reference for what normal progress looks like and when to flag concerns.

One practical habit: weigh yourself once a week, same morning, same conditions, and track the trend over four weeks rather than comparing Tuesday to Wednesday. The day-to-day noise is significant enough to mislead even when things are going well.

When should you speak to your prescriber rather than waiting?

If you have genuinely not lost any weight over six or more weeks at your current dose, do not simply continue and hope, raise it. Your prescriber can look at whether a dose increase is clinically appropriate, whether your medical history includes anything that might be affecting response, or whether a different approach is needed.

At nume, every repeat order goes through a clinical re-review before anything is dispensed. A prescriber (not an automated queue) reads your update and responds the same day. If you have concerns between orders, our team is reachable seven days a week. It is also worth reading through what to do when Mounjaro isn't working for a structured look at next steps.

For context on what the full treatment process looks like (including how private treatment compares to NHS access on cost) our Mounjaro pricing overview covers it plainly. And if you are considering starting or reviewing your treatment, speaking to our prescribers is the right first move.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions